BCR and neoplasm: Other studies also reported that CD79A and CD79B mutations modify distal BCR signaling in collaboration with other mutations of the BCR signaling network via modulation of NF-κB signaling (with an effect on survival, apoptosis, and proliferation of tumor cells).